Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Arnon Nagler Maud Ngoya Jacques-Emmanuel GalimardMyriam LabopinMartin Bornhäuser Matthias Stelljes Juergen FinkeArnold GanserHerman EinseleNicolaus KrögerArne BrechtWolfgang Andreas BethgeMatthias EdingerAlexander Dmitrievich KulaginJakob PasswegIgor Wolfgang BlauAhmet ElmaagacliKerstin Schäfer-EckartUwe PlatzbeckerThomas SchroederDonald BunjesJohanna TischerSonja Martin Alexandros SpirydonidisSebastian GiebelBipin P SavaniMohamad Mohty

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Outcome of unrelated transplantation for patients with ref/rel AML has improved in the last two decades, rescuing about one third of the patients. See related commentary by Adrianzen-Herrera and Shastri, p. 4167.

Keyphrases

stem cell transplantation
acute myeloid leukemia
high dose
end stage renal disease
ejection fraction
newly diagnosed
allogeneic hematopoietic stem cell transplantation
chronic kidney disease
prognostic factors
cord blood
diffuse large b cell lymphoma
bone marrow
low dose
hodgkin lymphoma